Invention Grant
- Patent Title: Factor XII inhibitors for the treatment of neurological inflammatory disorders
-
Application No.: US14374300Application Date: 2013-01-31
-
Publication No.: US09957329B2Publication Date: 2018-05-01
- Inventor: Sven Meuth , Kerstin Goebel , Christoph Kleinschnitz , Brent McKenzie , Marc Nolte
- Applicant: CSL BEHRING GMBH , CSL LTD. , JULIUS-MAXIMILIANS-UNIVERSITAET-WUERZBURG , WESTFAELISCHE WILHELMS-UNIVERSITAET MUENSTER
- Applicant Address: DE Marburg AU Parkville DE Wuerzburg DE Muenster
- Assignee: CSL Behring GmbH,CSL Ltd.,Julius-Maximilians-Universitaet-Wuerzburg,Westfaelische Wilhelms-Universitaet Muenster
- Current Assignee: CSL Behring GmbH,CSL Ltd.,Julius-Maximilians-Universitaet-Wuerzburg,Westfaelische Wilhelms-Universitaet Muenster
- Current Assignee Address: DE Marburg AU Parkville DE Wuerzburg DE Muenster
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Priority: EP12153341 20120131
- International Application: PCT/EP2013/051832 WO 20130131
- International Announcement: WO2013/113774 WO 20130808
- Main IPC: A61K38/16
- IPC: A61K38/16 ; A61K38/17 ; A61K38/48 ; A61K39/395 ; C07K16/40 ; A61K38/06 ; A61K38/55 ; A61K38/57 ; C07K14/81 ; C07K16/36 ; A61K39/00
Abstract:
This application relates to neurological inflammatory diseases, such as multiple sclerosis, and to methods of administering a Factor XII inhibitor to prevent, treat, or otherwise ameliorate the effects of a neurological inflammatory disease, such as multiple sclerosis. Agents and pharmaceutical compositions comprising agents which inhibit the activity of FXII are also provided.
Public/Granted literature
- US20140378653A1 Factor XII Inhibitors for the Treatment of Neurological Inflammatory Disorders Public/Granted day:2014-12-25
Information query
IPC分类:
